Found 65 matching trials
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
PHASE2The CHIP-AML22 Master protocol has the overall aim of increasing the cure r...
Location
Princess Máxima Center for pediatric oncology
Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients
PHASE2Recent advances in acute myeloid leukemia (AML) have been characterized by ...
IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
EARLY_PHASE1This trial is designed to determine the feasibility of conventional inducti...
Location
Abramson Cancer Center of the University of Pennsylvania
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
PHASE1This is an open-label, dose escalation Phase I study to evaluate the tolera...
Location
University of Chicago
Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes
PHASE2RATIONALE: Although used primarily to treat malignant disorders of the bloo...
Location
Florida Hospital Cancer Institute
Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma
PHASE2The present study is a multicenter, prospective phase II-study to evaluate ...
Location
University Medical Center Hamburg-Eppendorf
Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure
PHASE2The present trial will establish a prospective sequential Allogeneic Stem C...
Allo SCT in Amyloidosis Non-interventional Study
N/ALight-chain (AL-) amyloidosis is a very rare monoclonal plasma cell disorde...
Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT
PHASE1Human cytomegalovirus (CMV) is a benign infectious agent in the normal host...
Location
Duke University Medical Center
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets
NAIn the transplant community, there is debate regarding the most appropriate...
Location
Duke University Medical Center